glp -1 drugs New GLP-1 Guidelines for Type 2 Diabetes in 2025 Patients' Use GLP-1 Drugs for

Behavioral measures of cognition in APP/PS1 mice treated with Exendin-4 was significantly improved

28,29 Although highly effective, 30 patients must administer injections of exenatide multiple times a day leading to low patient compliance

Sonkusre P, Cameotra SS

The broader risk with any peptide therapy is using unregulated, online-sourced peptides without medical supervision

For each medication, we defined a start date (date of first redemption) and an end date (date of last redemption plus the number of daily doses redeemed on that date)

Afamelanotide is authorised in the regulated Scenesse implant for preventing phototoxicity in adults with erythropoietic protoporphyria